Transdermal delivery

New breakthrough methods to avoid injections

P.L.E.A.S.E.® Platform

Targeted transdermal drug delivery

P.L.E.A.S.E.®  is Pantec Biosolutions’ platform for the transdermal delivery of large molecule drugs. Although transdermal application of drugs is a very powerful administration route, there are still very few patches on the market. The reason for this is that only a few molecules are able to pass the outer skin layers passively to finally reach the blood capillaries in the dermis.

The outermost layer, the stratum corneum in particular, provides a strong barrier for molecules larger than 500 Dalton. So pretreating skin with microporation should be a route to effect successful transdermal delivery of larger proteins in patches. From transdermal to intraepidermal drug delivery using Pantec Biosolutions' proprietary laser- powered P.L.E.A.S.E.® extends the range of drugs that can be delivered transdermally. This novel application allows both low and high molecular weight drugs to be delivered transdermally.

P.L.E.A.S.E.® from small to large drugs

Transdermal delivery without molecular size limitation

In collaboration with our Centres of Excellence and leading patch development and manufacturing companies, Pantec Biosolutions develops novel topical formulations (e.g. ointments and skin patches) for use with P.L.E.A.S.E.®. We have active programmes in selected therapy areas for improved delivery of small drugs as well as enabling targeted large molecule drug delivery.

P.L.E.A.S.E.® is the method of choice for the transdermal application of infertility hormones and other large molecular weight drugs due to the following:

  • Simple and convenient to use by patients and health professionals
  • Precise, painless and reliable, independent of patient skin condition
  • Possibility to control the drug dose by variation of pores while drug permeation can be stopped by simply removing the patch
  • Delivers much more and higher molecular weight drugs than competing technologies.